Last reviewed · How we verify

NCT05992168: SRAME

Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)

Terminated NA Last updated 18 September 2025
What this trial tests

NA trial testing Stent-Retriever in PE - Pulmonary Embolism in 1 participant. Terminated before completion.

Timeline
3 January 2024
Primary endpoint
17 December 2024
17 December 2024

Quick facts

Lead sponsorSuzhou Zenith Vascular Scitech Co., Ltd.
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment1
Start date3 January 2024
Primary completion17 December 2024
Estimated completion17 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Suzhou Zenith Vascular Scitech Co., Ltd.

Who can join

Adults 18 to 75, any sex, with PE - Pulmonary Embolism or PE - Pulmonary Thromboembolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate treatment outcomes of patients diagnosed with pulmonary embolism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for PE - Pulmonary Embolism

Currently open trials in the same condition.

Other Suzhou Zenith Vascular Scitech Co., Ltd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05992168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing